Literature DB >> 1409405

Solid-state stability studies of 13-cis-retinoic acid and all-trans-retinoic acid using microcalorimetry and HPLC analysis.

X Tan1, N Meltzer, S Lindebaum.   

Abstract

The solid-state stabilities of 13-cis-retinoic acid and all-trans-retinoic acid in the presence and absence of oxygen were investigated. The samples were first evaluated using microcalorimetry. The rate laws of different samples under different conditions were deduced from the shapes of the heat flow curves, and the activation energies of the reactions were determined from Arrhenius plots. Under an air atmosphere, the decomposition of 13-cis-retinoic acid is an autocatalytic reaction, while all-trans-retinoic acid undergoes a zero-order process. The degradation of the two compounds at a selected elevated temperature was also determined utilizing HPLC analysis. This technique confirmed the decomposition kinetics. Hence, their half-lives and shelf lives at room temperature could be calculated. Under a nitrogen atmosphere, the microcalorimetric experiment showed a first-order phenomenon for both samples, but HPLC analysis showed no degradation, suggesting that the two samples, in the absence of oxygen, undergo only a physical change.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1409405     DOI: 10.1023/a:1015816225127

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  3 in total

1.  A kinetic study on crystallization of an amorphous lubricant.

Authors:  V P Lehto; E Laine
Journal:  Pharm Res       Date:  1997-07       Impact factor: 4.200

Review 2.  Pharmaceutical applications of microcalorimetry.

Authors:  M J Koenigbauer
Journal:  Pharm Res       Date:  1994-06       Impact factor: 4.200

3.  UVA is the major contributor to the photodegradation of tretinoin and isotretinoin: Implications for development of improved pharmaceutical formulations.

Authors:  Bassam M Tashtoush; Elaine L Jacobson; Myron K Jacobson
Journal:  Int J Pharm       Date:  2007-11-04       Impact factor: 5.875

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.